Myocardial Infarction - or Something Else?

Article

Radiating chest pain and sweating in a middle-aged man who describes a history of anxiety: looks like classic MI, but is it? Watch the video for clues.

A 47-year-old man presents to the emergency department with chest pain and sweating. He describes a history of anxiety and high blood pressure and is currently taking lisinopril and fluoxetine.

Please click here for full details about this case and the diagnosis, which  can be seen on ReelDx.com. (Free registration is required.)

[[{"type":"media","view_mode":"media_crop","fid":"29887","attributes":{"alt":"ReelDx","class":"media-image","id":"media_crop_9770087415466","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"3118","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]

This case was published with permission from ReelDx. Visit ReelDx.com for more cases.

 

 

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
5 elemental facts about electronic cigarettes all clinicians should know / image credit ©alexshalamov/stock.adobe.com

5 Elemental Facts About Electronic Cigarettes All Clinicians Should Know

Cameron Santoro
December 30th 2024
Article

The 5 summaries that follow cover harmful ingredients, associated health risks, industry marketing tactics, and current regulatory efforts.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes / Image credit: ©Argus/AdobeStock

FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes

Sydney Jennings
December 23rd 2024
Article

The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Sydney Jennings
October 25th 2023
Podcast

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

FDA Adds Black Box Warning to Fezolinetant Label, Advising of Rare but Serious Liver Injury / image credit ©Jerome/stock.adobe.com

FDA Adds Black Box Warning to Fezolinetant Label, Advising of Rare but Serious Liver Injury

Grace Halsey
December 23rd 2024
Article

The black box warning, the agency's most prominent alert, follows earlier additions to the original fezolinetant label about hepatic injury and regular LFT testing.

FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea with Obesity

FDA Approves Tirzepatide as First Drug for Obstructive Sleep Apnea with Obesity

Patient Care Editorial Staff
December 20th 2024
Article

This marks the second indication for tirzepatide in just more than a year, following its November 2023 approval for adults with obesity or overweight and weight-related medical problems.

© 2025 MJH Life Sciences

All rights reserved.